ACVR1B and cancer: Results from cancer genome-sequencing studies revealed that the activin A receptor Type 1B (ACVR1B) gene is mutated around 2% of PDAC samples, which may imply that ACVR1B could be a tumor suppressor gene in PDAC [102,103] (Figure 3).